Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group

Autor: Lars Bastholt, Søren M. Bentzen, Henning T. Mouridsen, Mogens Kjaer, Ole S. Nielsen, Susanne B. Gjedde, Mads Dalmark, Erik Sandberg, Carsten Rose, Dorte Pedersen, Per Pfeiffer, Preben Jakobsen

Publikováno v: Bastholt, L, Dalmark, M, Gjedde, S B, Pfeiffer, P, Pedersen, D, Sandberg, E, Kjær, M, Mouridsen, H T, Rose, C, Nielsen, O S, Jakobsen, P & Bentzen, S M 1996, ' Dose-Response Relationship of Epirubicin in the Treatment of Postmenopausal Patients with Metastatic Breast Cancer : A Randomized Study of Epirubicin at Four Different Dose Levels Performed by the Danish Breast Cancer Cooperative Group ', Journal of Clinical Oncology, vol. 14, no. 4, pp. 1146-1155 . https://doi.org/10.1200/JCO.1996.14.4.1146

PURPOSE To test for possible correlations between dose of single-drug epirubicin and efficacy/toxicity in postmenopausal women with metastatic breast cancer. The study also included analysis of a correlation between pharmacokinetic and pharmacodynami

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d49428527f5a18d0e579725d2741ae8
https://doi.org/10.1200/jco.1996.14.4.1146

Prognostic indicators for malignant tumours of the parotid gland

Autor: Grethe Harbo, Dorte Pedersen, Helmer Søgaard, Jens Overgaard, Troels Bundgaard

Publikováno v: Harbo, G, Bundgaard, T, Pedersen, D, Søgaard, H & Overgaard, J 2002, ' Prognostic indicators for malignant tumours of the parotid gland ', Clinical Otolaryngology, vol. 27, no. 6, pp. 512-516 . < http://www.ncbi.nlm.nih.gov/pubmed/12472522 >
Harbo, G, Bundgaard, T, Pedersen, D, Søgaard, H & Overgaard, J 2002, ' Prognostic indicators for malignant tumours of the parotid gland ' Clin. Otolaryngol., vol. 27, no. 6, pp. 512-516 .

The best treatment of malignant parotid tumours still remains to be defined, and a better knowledge about the tumour features that predict the treatment result is needed. The histological classification of parotid tumours may present difficulties on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c54bc3fc89427fd98e7895b442001b
https://pure.au.dk/portal/da/publications/prognostic-indicators-for-malignant-tumours-of-the-parotid-gland(8a0376f0-9841-11da-bee9-02004c4f4f50).html

Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now!

Autor: Jens Overgaard, Michael Vaeth, Søren M. Bentzen, Dorte Pedersen

Publikováno v: Bentzen, S M, Vaeth, M, Pedersen, D E & Overgaard, J 1995, ' Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now! ', International Journal of Radiation Oncology, Biology, Physics, vol. 32, no. 5, pp. 1531-1534 . https://doi.org/10.1016/0360-3016(95)00262-W

Cancer is a life-threatening disease, and the prime measure of treatment success has logically been patient survival. Treatment-related morbidity, the back-side of the coin, has often been regarded as the unavoidable price that the patient had to pay

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c03e0dbfaeab950cb5e331612b1e51
https://pure.au.dk/portal/da/publications/why-actuarial-estimates-should-be-used-in-reporting-late-normaltissue-effects-of-cancer-treatment--now(38b57854-b651-4126-90fc-5aa78a03e4c0).html

Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix

Autor: Søren M. Bentzen, Jens Overgaard, Dorte Pedersen

Publikováno v: Pedersen, D, Bentzen, S M & Overgaard, J 1994, ' Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix ', International Journal of Radiation Oncology, Biology, Physics, vol. 29, no. 5, pp. 941-52 . https://doi.org/10.1016/0360-3016(94)90387-5

Purpose : to evaluate the early and late radiotherapeutic morbidity after combined external and intracavitary radiotherapy to the uterine cervix. Methods and Materials : The morbidity in 442 consecutive cervical cancer patients FIGO Stage 1113 (139),

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5317b39387eb7087560e17ff4ef5e6e4
https://pure.au.dk/portal/da/publications/early-and-late-radiotherapeutic-morbidity-in-442-consecutive-patients-with-locally-advanced-carcinoma-of-the-uterine-cervix(88bf90ee-e544-44c7-9881-f65df0c44129).html

Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis

Autor: O. Elbrønd, Jens Overgaard, Marie Overgaard, Helmer Søgaard, Dorte Pedersen

Publikováno v: Pedersen, D, Overgaard, J, Søgaard, H, Elbrønd, O & Overgaard, M 1992, ' Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis ', The Laryngoscope, vol. 102, no. 9, pp. 1064-9 . https://doi.org/10.1288/00005537-199209000-00019

The UICC 1987 classification system was used to retrospectively analyze the treatment results and prognostic factors in 110 consecutive patients. All of the patients had malignant parotid tumors which had been diagnosed and treated during the period

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bec70319e1b5f944fc7b43e357cdba45
https://pure.au.dk/portal/da/publications/malignant-parotid-tumors-in-110-consecutive-patients-treatment-results-and-prognosis(413a080f-14f7-4267-8e4d-213548a2859a).html